Also, the percentage of CD4+ naïve, central memory, effector memory, and effector memory RA+ (EMRA) cells were comparable between the patients who did or did not develop rejection (Supplementary Figure 1 and Supplementary Table 2). This evidence concerns the gene CD4 and rheumatoid arthritis.